
June 12 (Reuters) - Lexaria Bioscience Corp LEXX.O:
LEXARIA BIOSCIENCE CORP - ENTERS CHANGE ORDER TO TERMS OF ITS PROJECT AGREEMENT WITH NOVOTECH - SEC FILING
LEXARIA BIOSCIENCE CORP - CHANGE ORDER ADDS 5TH STUDY ARM FOR DEHYDRATECH-TIRZEPATIDE CAPSULES IN ITS AUSTRALIAN CLINICAL STUDY- SEC FILING
LEXARIA BIOSCIENCE CORP - CHANGE ORDER RESULTS IN ADDITIONAL COSTS OF AU$1.9 MILLION - SEC FILING
Source text: [ID:n0001640334-25-001030]